Journal article · 2023 · Open access
AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS
Annals of the Rheumatic Diseases, 82, 2114–2115 · Published 1 June 2023 · DOI 10.1136/annrheumdis-2023-eular.3450
In brief
“AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS” is a 2023 journal article by Fulden Sarı and 8 co-authors, published in Annals of the Rheumatic Diseases. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Annals of the Rheumatic Diseases.
- Citations
- 0
- Authors
- 9
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sarı, F., Bazancir‐Apaydin, Z., Apaydın, H., KAYAALP, M., Erden, A., Güven, S. C., Armağan, B., Omma, A., & Küçükşahin, O. (2023). AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases, 82, 2114–2115. https://doi.org/10.1136/annrheumdis-2023-eular.3450
MLA 9
Sarı, Fulden, et al. “AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS.” Annals of the Rheumatic Diseases, vol. 82, 2023, pp. 2114–2115. https://doi.org/10.1136/annrheumdis-2023-eular.3450.
Chicago
Sarı, Fulden, Zilan Bazancir‐Apaydin, Hakan Apaydın, Mehmet KAYAALP, Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, and Orhan Küçükşahin. 2023. “AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS.” Annals of the Rheumatic Diseases 82: 2114–2115. https://doi.org/10.1136/annrheumdis-2023-eular.3450.
Harvard
Sarı, F. et al. (2023) ‘AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS’, Annals of the Rheumatic Diseases, 82, pp. 2114–2115. doi:10.1136/annrheumdis-2023-eular.3450.
IEEE
F. Sarı et al., “AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS,” Annals of the Rheumatic Diseases, vol. 82, pp. 2114–2115, 2023, doi: 10.1136/annrheumdis-2023-eular.3450.
BibTeX
@article{sar2023reliability,
title = {{AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS}},
author = {Sarı, Fulden and Bazancir‐Apaydin, Zilan and Apaydın, Hakan and KAYAALP, Mehmet and Erden, Abdülsamet and Güven, Serdar Can and Armağan, Berkan and Omma, Ahmet and Küçükşahin, Orhan},
journal = {Annals of the Rheumatic Diseases},
year = {2023},
volume = {82},
pages = {2114--2115},
doi = {10.1136/annrheumdis-2023-eular.3450},
url = {https://doi.org/10.1136/annrheumdis-2023-eular.3450}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- systemic sclerosis
- Turkish translation
- cross-cultural adaptation
- skin involvement
- quality of life
- skin fibrosis
- construct validity
- test-retest reliability
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Sarı, F., Bazancir‐Apaydin, Z., Apaydın, H., KAYAALP, M., Erden, A., Güven, S. C., Armağan, B., Omma, A., & Küçükşahin, O. (2023). AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases, 82, 2114–2115. https://doi.org/10.1136/annrheumdis-2023-eular.3450
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annals of the Rheumatic Diseases: sign in and open the PDF from this page.
Who wrote this paper?
Fulden Sarı, Zilan Bazancir‐Apaydin, Hakan Apaydın, Mehmet KAYAALP, Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Küçükşahin.
What is the DOI of this paper?
10.1136/annrheumdis-2023-eular.3450, permanently at https://doi.org/10.1136/annrheumdis-2023-eular.3450. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.